SLC22A12 and hyperuricemia: Furthermore, since inhibitors of Urat1 are increasingly used to treat human hyperuricemia, the clarification of the role of Urat1 in individual in vivo metabolic pathways as well as overall redox state should be helpful understanding potential drug-metabolite interactions and unexpected toxicity from URAT1 inhibiting drugs.